Loading clinical trials...
Loading clinical trials...
Combination With Regulatory T Cell Levels and Cardiac Magnetic Resonance Imaging (CMR) to Assess the Severity and Prognosis of Reperfusion Injury After Primary PCI in STEMI Patients (TregCMRRS)
This study aims to determine whether combination with regulatory T cell (Treg) levels and cardiac magnetic resonance imaging (CMR) are predictive of the severity of reperfusion injury following myocardial infarction and the prognosis in STEMI patients receiving primary percutaneous coronary intervention (PPCI).
Age
All ages
Sex
ALL
Healthy Volunteers
No
Beijing Friendship Hospital, Capital Medical University
Beijing, Beijing Municipality, China
Start Date
July 1, 2019
Primary Completion Date
August 31, 2021
Completion Date
August 31, 2021
Last Updated
June 26, 2019
250
ESTIMATED participants
Treg levels and CMR results
OTHER
Lead Sponsor
Beijing Friendship Hospital
NCT06438315
NCT07160491
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and ConditionsNCT06678074